ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
22,59
0,455
(2,06%)
Geschlossen 08 Juni 10:00PM

Pfizer Inc (PFE) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
22,59
( 2,06% )
Gebot
22,555
Fragen
22,625
Volumen
115.374
22,08 Tagesbereich 22,735
19,982 52-Wochen-Bereich 24,915
Marktkapitalisierung
Handelsende
22,135
Handelsbeginn
22,195
Letzte Trade
1700
@
22.56
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
37.220.295 €
Ausgegebene Aktien
5.699.444.169
Dividendenrendite (LTM)
1,72 (6,79%)
Kurs-Gewinn-Verhältnis
19,95
Gewinn pro Aktie (EPS)
1,31
Erlöse (LTM)
63,32B
Nettogewinn (LTM)
7,49B

Über Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic dise... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
New York, United States
Gegründet
2026
Pfizer Inc is listed in the Healthcare sector of the Tradegate (DE) with ticker PFE. The last closing price for Pfizer was 22,14 €. Over the last year, Pfizer shares have traded in a share price range of 19,982 € to 24,915 €.

Pfizer currently has 5.699.444.169 shares in issue. The market capitalisation of Pfizer is 128,75 € billion. Pfizer has a price to earnings ratio (PE ratio) of 19.95.

PFE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.1950.87073007367722.39522.73521.728933622.08699967DE
40.140.62360801781722.4522.7721.638787522.05541735DE
12-0.725-3.1095861033723.31524.91521.6310245522.90591863DE
260.5452.4722159219822.04524.91521.08512211022.51656632DE
521.9659.5272727272720.62524.91519.98211901321.92651614DE
156-13.16-36.811188811235.7538.65518.710123223.93425337DE
260-9.7-30.040260142532.2954.5118.78301929.20946917DE

PFE - Frequently Asked Questions (FAQ)

What is the current Pfizer Inc share price?
The current share price of Pfizer Inc is 22,59 €
How many Pfizer Inc shares are in issue?
Pfizer Inc has 5.699.444.169 shares in issue
What is the market cap of Pfizer Inc?
The market capitalisation of Pfizer Inc is EUR 128,75B
What is the 1 year trading range for Pfizer Inc share price?
Pfizer Inc has traded in the range of 19,982 € to 24,915 € during the past year
What is the PE ratio of Pfizer Inc?
The price to earnings ratio of Pfizer Inc is 19,95
What is the cash to sales ratio of Pfizer Inc?
The cash to sales ratio of Pfizer Inc is 2,35
What is the registered address of Pfizer Inc?
The registered address for Pfizer Inc is 66 Hudson Boulevard East, New York, New York, 10001-2192
What is the Pfizer Inc website address?
The website address for Pfizer Inc is www.pfizer.com
Which industry sector does Pfizer Inc operate in?
Pfizer Inc operates in the Pharmaceuticals sector

PFE Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen